TOKYO, May 7 (Reuters) - Japanese drugmaker Shionogi (4507.T), opens new tab said on Wednesday that it will acquire Torii Pharmaceutical (4551.T), opens new tab, a subsidiary of Japan Tobacco ...

OSAKA/TOKYO -- Japanese drugmaker Shionogi said Wednesday that it will acquire Torii Pharmaceutical and other assets from Japan Tobacco in a deal worth around 160 billion yen ($1.1 billion ...

Shares of Japanese drugmaker Shionogi & Co. dropped the most in almost a month after the Nikkei newspaper reported the company will buy Torii Pharmaceutical Co. for about ¥150 billion ($1 billion).

Shionogi & Co. Ltd. (4507.TO) Osaka Year Ended March 31 GROUP 2025 2024 Revenue Y438.27 bln Y435.08 bln Operating Profit Y156.60 bln Y153.31 bln Pretax Profit Y200.75 bln Y198.28 bln Net Profit ...

Shionogi & Co., Ltd. stock price live, this page displays TYO 4507 stock exchange ... Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral ...

Shionogi & Co. said it plans to acquire Japan Tobacco Inc. (JT) subsidiaries Torii Pharmaceutical Co. and Akros Pharma Inc. for ¥160 billion (US$1.1 billion) to expand its global R&D business. The two ...

Dr. Gomez is Chief Medical Officer of Shionogi & Co., Ltd., a Pharmaceutical Company with Headquarters in Osaka, Japan, that is focused on the development of innovative treatments for infectious ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii Pharma, which sells medicines for skin disorders, kidney disease, and ...

Digital health company Akili is on the brink of its first major expansion beyond the US, partnering with Shionogi to file a localised version of its attention deficit hyperactivity disorder (ADHD ...

NEW YORK -- Uncertainty fueled by U.S. tariffs has contributed to a drop in global mergers and acquisitions to a 20-year low, dashing earlier hopes of a deregulation-driven "Trump bump." A total ...